Related Experiment Video
Updated: May 7, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Some issues in predicting patient recruitment in multi-centre clinical trials
Andisheh Bakhshi1, Stephen Senn, Alan Phillips
1School of Mathematics and Statistics, University of Glasgow, Glasgow, G12 8QW, U.K.; Department of Mathematics and Statistics, University of Strathclyde, Glasgow, G1 1XH, U.K.
This study introduces a new hierarchical model for forecasting clinical trial completion times, extending previous work by Anisimov and Fedorov. The enhanced model improves predictions for trials yet to begin, aiding in better clinical trial planning.
Area of Science:
- Clinical trial methodology
- Statistical modeling
- Biostatistics
Background:
- Previous models by Anisimov and Fedorov used Gamma-Poisson mixtures (negative binomial) for forecasting trial recruitment and completion times.
- These models effectively link frequency and time domains, correlating negative binomial distributions with Type VI Pearson distributions.
- Forecasting is crucial not only for ongoing trials but also for those not yet initiated.
Purpose of the Study:
- To extend existing models for forecasting clinical trial completion times by introducing a higher hierarchical level.
- To develop a method for forecasting completion times for trials that have not yet started.
- To present a practical approach using an orthogonal parameterization of the Gamma distribution.
Main Methods:
- Utilized a hierarchical modeling approach with an orthogonal parameterization of the Gamma distribution.
- Modeled the two parameters of the Gamma distribution separately.
- Applied the method to data from 18 multi-centre clinical trials.
Main Results:
- The proposed hierarchical model provides a framework for forecasting trial completion times, particularly for new trials.
- Demonstrated the application of the orthogonal parameterization of the Gamma distribution in this context.
- The method was successfully illustrated using real-world clinical trial data.
Conclusions:
- The developed hierarchical model offers a valuable extension for predicting clinical trial durations.
- This approach enhances the ability to forecast completion times for trials at any stage, including those yet to commence.
- The method provides practical insights for improving clinical trial planning and resource allocation.
More Related Videos
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bioavailability Study Design: Healthy Subjects Versus Patients
Analysis of Population Pharmacokinetic Data
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Longitudinal Research

